Palisade Bio Inc.

0.66
-0.01 (-1.46%)
At close: Apr 02, 2025, 3:47 PM
0.67
1.18%
After-hours: Apr 02, 2025, 07:50 PM EDT

Palisade Bio Statistics

Share Statistics

Palisade Bio has 4.4M shares outstanding. The number of shares has increased by 369.53% in one year.

Shares Outstanding 4.4M
Shares Change (YoY) 369.53%
Shares Change (QoQ) 58.95%
Owned by Institutions (%) 17.25%
Shares Floating 4.36M
Failed to Deliver (FTD) Shares 1.77K
FTD / Avg. Volume 0.3%

Short Selling Information

The latest short interest is 43.11K, so 1.56% of the outstanding shares have been sold short.

Short Interest 43.11K
Short % of Shares Out 1.56%
Short % of Float 1.57%
Short Ratio (days to cover) 0.29

Valuation Ratios

The PE ratio is -0.16 and the forward PE ratio is -0.39. Palisade Bio's PEG ratio is 0.

PE Ratio -0.16
Forward PE -0.39
PS Ratio 0
Forward PS null
PB Ratio 0.31
P/FCF Ratio -0.19
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Palisade Bio.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.01.

Current Ratio 3.24
Quick Ratio 3.24
Debt / Equity 0.01
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 1238.25

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.8M
Employee Count 8
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -88.7% in the last 52 weeks. The beta is 1.41, so Palisade Bio's price volatility has been higher than the market average.

Beta 1.41
52-Week Price Change -88.7%
50-Day Moving Average 1
200-Day Moving Average 2.67
Relative Strength Index (RSI) 30.97
Average Volume (20 Days) 585.82K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -14.86M
Net Income -14.44M
EBITDA -14.86M
EBIT -14.45M
Earnings Per Share (EPS) -10.19
Full Income Statement

Balance Sheet

The company has 9.82M in cash and 90K in debt, giving a net cash position of 9.73M.

Cash & Cash Equivalents 9.82M
Total Debt 90K
Net Cash 9.73M
Retained Earnings -135.94M
Total Assets 10.88M
Working Capital 7.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.19M and capital expenditures 0, giving a free cash flow of -12.19M.

Operating Cash Flow -12.19M
Capital Expenditures 0
Free Cash Flow -12.19M
FCF Per Share -8.61
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PALI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for PALI is $23, which is 3384.8% higher than the current price. The consensus rating is "Buy".

Price Target $23
Price Target Difference 3384.8%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Apr 8, 2024. It was a backward split with a ratio of 1:15.

Last Split Date Apr 8, 2024
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -20.55
Piotroski F-Score 3